Aviana (AVAH) Q1 2023: Preferred Payer Volume Rises to 13%, Accelerating Rate-Driven Labor Recovery
Aviana’s Q1 marked a pivotal shift as preferred payer volumes climbed to 13%, fueling targeted labor recovery and wage-driven volume growth. The company’s legislative wins in Oklahoma and traction in Texas and California signal a strategic pivot toward higher reimbursement and value-based partnerships. With guidance unchanged, the next 60 days will determine whether rate momentum can fully unlock Aviana’s labor-constrained growth potential.
Summary
- Preferred Payer Expansion: Aviana accelerated its shift toward higher-reimbursing, value-based payers, boosting recruitment and volume growth.
- Legislative Rate Wins: Early success in Oklahoma, with progress in Texas and California, is reshaping labor supply and patient access.
- Guidance Hinges on Rate Execution: The company’s outlook depends on securing further rate increases in key states in the coming quarter.
Business Overview
Aviana Healthcare Holdings is a provider of home and community-based healthcare services, generating revenue primarily through Private Duty Services (PDS), Home Health and Hospice, and Medical Solutions. The company’s business model centers on delivering skilled nursing and care in patient homes, reimbursed by government and managed care payers, with a growing emphasis on preferred payer, value-based contracts that reward clinical outcomes and cost savings.
Performance Analysis
Revenue increased 3.5% year-over-year, led by PDS and Medical Solutions, while Home Health and Hospice remained pressured. PDS revenue grew 6.5% on higher rates and modest volume gains, with per-hour rates up 4.7% year-over-year. However, adjusted EBITDA fell 25%, reflecting persistent labor cost inflation and the lag between reimbursement and wage pass-through.
Gross margin in PDS was stable at 27.9%, with sequential improvement in cost per hour and spread, as Oklahoma’s retroactive rate increase allowed for accelerated caregiver recruitment. Home Health and Hospice saw a 15.8% revenue decline but posted improved margins and admissions, signaling early benefits from cost initiatives. Medical Solutions revenue rose 10.7%, capturing share as competitors exited the market.
- Labor-Driven Margin Compression: Wage inflation continues to pressure profitability, but targeted rate increases are beginning to offset these headwinds.
- Volume Tied to Reimbursement: Caregiver recruitment and volume growth are tightly linked to securing higher rates, especially from preferred payers and legislative wins.
- Cash Flow Volatility: Q1 saw positive operating cash flow from one-time items, but management expects a return to positive cash flow by year-end as initiatives mature.
The quarter’s results reinforce Aviana’s thesis: unlocking labor supply and driving volume growth is contingent on successful rate negotiations, not underlying demand, which remains robust.
Executive Commentary
"Our ability to recruit and retain the best talent is a function of rate... Since the Oklahoma rate increase, we have doubled the number of caregivers hired per week in Oklahoma, demonstrating the impact rate increases have on our ability to attract caregivers at the right wage profile."
Jeff Shainer, Chief Executive Officer
"It is clear to us that shifting caregiver capacity to those preferred payers who value our partnership is the path forward at Aviana. As we make progress in 2023 with the rate environment, we will pass through wage improvements and other benefits to our caregivers in the ongoing effort to better improve our volumes."
Dave Afshar, Chief Financial Officer
Strategic Positioning
1. Preferred Payer Penetration
Preferred payers, defined as those offering above-market reimbursement and value-based payments, now represent 13% of PDS volume, up from 10% at year-end. These contracts enable Aviana to offer higher wages, attract more caregivers, and drive patient admissions while earning value-based bonuses for clinical outcomes and reduced hospitalizations.
2. Legislative Rate Advocacy
Aviana’s legislative strategy targets double-digit rate increases in key states, with Oklahoma already secured and Texas and California pending. These three states together account for 25% of PDS revenue, making the outcome of ongoing negotiations critical to both wage competitiveness and capacity expansion.
3. Labor Supply as a Growth Lever
The company’s growth is fundamentally constrained by labor supply, not demand. Management’s approach is to rapidly pass through rate gains to caregivers, reactivating inactive nurses and increasing shift fill rates. This dynamic is most evident in Oklahoma, where a retroactive rate increase immediately doubled weekly caregiver hires and increased shift uptake among existing staff.
4. Segment Realignment and Cost Initiatives
Home Health and Hospice is undergoing cost optimization, with sequential margin improvement and admissions recovery, while Medical Solutions is capitalizing on market exits by competitors to expand its national footprint and payer relationships.
Key Considerations
This quarter’s results highlight Aviana’s pivot from broad-based cost control to targeted rate-driven volume expansion, with execution risk now centered on legislative and payer negotiations. The company’s ability to rapidly redeploy labor and drive incremental volume is a function of its preferred payer and rate advocacy strategies.
Key Considerations:
- Rate-Dependent Growth Trajectory: Near-term revenue and margin expansion are contingent on securing further rate increases in Texas and California.
- Labor Supply Elasticity: Caregiver recruitment is highly responsive to wage increases, but underlying wage inflation remains a structural headwind.
- Value-Based Bonus Potential: Preferred payer contracts include value-based bonuses, adding a secondary profit lever beyond base reimbursement rates.
- Cash Flow Timing Risk: Positive Q1 cash flow was aided by one-time legal settlements; sustainable free cash flow is expected only in the back half of the year.
Risks
Aviana’s outlook is exposed to legislative risk, as failure to secure anticipated rate increases in Texas or California would constrain labor supply and volume growth. Wage inflation and regulatory proposals, such as CMS’s direct care compensation threshold, pose potential precedent risks to margin structure. Cash flow remains volatile, with positive operating cash flow dependent on execution of cost and rate initiatives in the second half.
Forward Outlook
For Q2, Aviana guided to:
- Continued revenue and adjusted EBITDA growth, contingent on rate increases in key states
- Sequential improvement in all business segments as cost and rate initiatives mature
For full-year 2023, management reiterated guidance:
- Revenue of greater than $1.84 billion
- At least $130 million in adjusted EBITDA
Management highlighted several factors that will drive performance:
- Timing and magnitude of legislative rate increases in Texas and California
- Ability to shift caregiver capacity to preferred payers and optimize wage pass-through
Takeaways
Aviana’s Q1 demonstrated that targeted rate advocacy and preferred payer expansion are unlocking labor supply and driving incremental growth, but full-year results will hinge on legislative execution in the next two months.
- Labor Supply as Growth Gatekeeper: Wage-driven recruitment is the decisive lever for volume growth, with Oklahoma serving as a proof point for rapid capacity expansion when rates move.
- Preferred Payer Model Gains Traction: Value-based contracts are increasing in share and importance, boosting both volume and bonus-driven profitability, but require ongoing operational agility.
- Legislative Outcomes Will Set the Pace: Investors should watch the outcome of Texas and California negotiations, as these will determine whether Aviana’s growth accelerates or stalls in the second half.
Conclusion
Aviana’s Q1 results validate its pivot toward preferred payer partnerships and legislative rate advocacy as the primary levers for unlocking labor-constrained growth. The next 60 days will be decisive, with legislative outcomes in Texas and California set to determine whether Aviana can fully capitalize on robust demand and return to sustainable margin expansion.
Industry Read-Through
Aviana’s experience underscores a broader industry shift: labor supply, not demand, is the gating factor for growth in home-based care. Rate-driven recruitment and value-based payer partnerships are emerging as best practices for providers navigating wage inflation and capacity constraints. Legislative advocacy and alignment with managed care organizations are now essential for scaling home health businesses, with implications for all players exposed to Medicaid and value-based reimbursement. CMS’s proposed compensation rules highlight the ongoing regulatory risk facing the sector, reinforcing the need for operational flexibility and payer diversification.